Literature DB >> 30498069

Ineffective erythropoiesis of TET2 deficiency.

Don M Wojchowski1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30498069      PMCID： PMC6265648          DOI： 10.1182/blood-2018-10-878645

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

Review 1.  TET2 in Normal and Malignant Hematopoiesis.

Authors:  Robert L Bowman; Ross L Levine
Journal:  Cold Spring Harb Perspect Med       Date:  2017-08-01       Impact factor: 6.915

Review 2.  How I treat chronic myelomonocytic leukemia.

Authors:  Eric Solary; Raphael Itzykson
Journal:  Blood       Date:  2017-06-01       Impact factor: 22.113

Review 3.  Turning the tide in myelodysplastic/myeloproliferative neoplasms.

Authors:  Michael W N Deininger; Jeffrey W Tyner; Eric Solary
Journal:  Nat Rev Cancer       Date:  2017-06-23       Impact factor: 60.716

4.  TAM receptors and the regulation of erythropoiesis in mice.

Authors:  Hongmei Tang; Song Chen; Haikun Wang; Hui Wu; Qingxian Lu; Daishu Han
Journal:  Haematologica       Date:  2009-02-11       Impact factor: 9.941

5.  Mutation in TET2 in myeloid cancers.

Authors:  François Delhommeau; Sabrina Dupont; Véronique Della Valle; Chloé James; Severine Trannoy; Aline Massé; Olivier Kosmider; Jean-Pierre Le Couedic; Fabienne Robert; Antonio Alberdi; Yann Lécluse; Isabelle Plo; François J Dreyfus; Christophe Marzac; Nicole Casadevall; Catherine Lacombe; Serge P Romana; Philippe Dessen; Jean Soulier; Franck Viguié; Michaela Fontenay; William Vainchenker; Olivier A Bernard
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

6.  TET2 deficiency leads to stem cell factor-dependent clonal expansion of dysfunctional erythroid progenitors.

Authors:  Xiaoli Qu; Shijie Zhang; Shihui Wang; Yaomei Wang; Wei Li; Yumin Huang; Huizhi Zhao; Xiuyun Wu; Chao An; Xinhua Guo; John Hale; Jie Li; Christopher D Hillyer; Narla Mohandas; Jing Liu; Karina Yazdanbakhsh; Francesca Vinchi; Lixiang Chen; Qiaozhen Kang; Xiuli An
Journal:  Blood       Date:  2018-09-25       Impact factor: 22.113

Review 7.  TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.

Authors:  Hideaki Nakajima; Hiroyoshi Kunimoto
Journal:  Cancer Sci       Date:  2014-09-03       Impact factor: 6.716

Review 8.  Targeting Gas6/TAM in cancer cells and tumor microenvironment.

Authors:  Guiling Wu; Zhiqiang Ma; Yicheng Cheng; Wei Hu; Chao Deng; Shuai Jiang; Tian Li; Fulin Chen; Yang Yang
Journal:  Mol Cancer       Date:  2018-01-31       Impact factor: 27.401
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.